According to the latest data from the Hong Kong Stock Exchange, on September 25, Yang Jianxin increased his holdings in CStone Pharmaceuticals (02616) by 150,000 shares at a price of HK$7.7982 per share, with a total transaction value of approximately HK$1.1697 million. Following this increase, his latest shareholding stands at approximately 70.2427 million shares, representing a 4.76% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.